Search

Your search keyword '"Rubin BK"' showing total 314 results

Search Constraints

Start Over You searched for: Author "Rubin BK" Remove constraint Author: "Rubin BK"
314 results on '"Rubin BK"'

Search Results

203. Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis.

205. A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children.

206. Hyperosmolar solutions stimulate mucus secretion in the ferret trachea.

207. Macrolide antibiotics, bacterial populations and inflammatory airway disease.

209. The delivery of inhaled medication to the young child.

210. Cystic fibrosis: bench to bedside 2003.

211. Pharmacological approaches to discovery and development of new mucolytic agents.

212. Nebulizer therapy for children: the device-patient interface.

213. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy.

214. Physiology of airway mucus clearance.

215. The pharmacologic approach to airway clearance: mucoactive agents.

216. Sputum processing for evaluation of inflammatory mediators.

217. Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis.

218. Aerosol therapy for children.

219. Regulation of secretion from mucous and serous cells in the excised ferret trachea.

220. Propofol and methohexital have no significant effect on mucus secretion or clearance in the anesthetized dog.

221. Histopathology of fatal asthma: drowning in mucus.

222. Macrolide antibiotics as biological response modifiers.

223. Respiratory-related quality of life: relation to pulmonary function, functional exercise capacity, and sputum biophysical properties.

226. The well-stressed intensivist.

227. Evaluating the efficacy of mucoactive aerosol therapy.

228. Consensus statement: aerosols and delivery devices. American Association for Respiratory Care.

229. Experimental macromolecular aerosol therapy.

230. Mucus-controlling agents: past and present.

231. Autonomic cardiovascular control in children with obstructive sleep apnea.

232. An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol.

234. Bronchial mucus properties in lung cancer: relationship with site of lesion.

235. Emerging therapies for cystic fibrosis lung disease.

237. Pseudomonas aeruginosa alginate is a potent secretagogue in the isolated ferret trachea.

238. Perfluorooctyl bromide (perflubron) stimulates mucin secretion in the ferret trachea.

239. PCR detection of viral nucleic acid in fatal asthma: is the lower respiratory tract a reservoir for common viruses?

240. Who will benefit from DNase?

241. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians.

242. Nitric oxide metabolites in cystic fibrosis lung disease.

244. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial.

245. Regulation of mucin secretion in the ferret trachea.

246. Promoting meconium clearance from the lungs of the neonatal piglet with asymmetric high frequency oscillation.

247. Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis.

248. Ultrasonic nebulization of albuterol is no more effective than jet nebulization for the treatment of acute asthma in children.

249. The surface and transport properties of meconium and reconstituted meconium solutions.

Catalog

Books, media, physical & digital resources